Global Endowment Management, LP Abb Vie Inc. Transaction History

Global Endowment Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $288,179 - $317,250	-2,817 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $44,269 - $59,768	-550 Reduced 16.34%	2,817 $302,000
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $242,861 - $303,871	3,367 New	3,367 $298,000

3,653

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Global Endowment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Global Endowment Management, LP with notifications on news.